Literature DB >> 9145633

What explains black-white differences in survival in idiopathic dilated cardiomyopathy? The Washington, DC, Dilated Cardiomyopathy Study.

S S Coughlin1, L Myers, R K Michaels.   

Abstract

We have found race to be an independent predictor of mortality in a preliminary analysis of data from an ongoing study of patients with idiopathic dilated cardiomyopathy. Our previous, analyses, however, were based on only 12 to 24 months of follow-up. In the present analysis, which is based on up to 5 years of follow-up, we extended our earlier observations and examined whether other socioeconomic factors account for the association with race. A total of 128 patients from five Washington, DC, area hospitals were included in the analysis. One hundred three (80.5%) of the patients were black and 25 (19.5%) were white. The black patients were less likely to have private health insurance, less educated on average, and more likely to have a household income < or = $15,000. No racial differences were found in cardiac medication usage, with the exception of beta blockers and antiarrhythmics. The cumulated survival among black patients at 12 and 60 months was 71.5% and 39.1%, respectively, compared with 92% and 31.4% among whites. Age, ventricular arrhythmias, and ejection fraction were significant predictors of survival in univariate analysis. The univariate association with black race was of borderline significance. In multivariable analysis using the proportional hazards model, age and ejection fraction were significant independent predictors of survival. The association with ventricular arrhythmias was of borderline significance. The association with black race, which was statistically nonsignificant, was diminished even further by adjustment for income and type of health insurance. Thus, the previously reported association with black race may be accounted for by socioeconomic factors related to access to health care.

Entities:  

Mesh:

Year:  1997        PMID: 9145633      PMCID: PMC2608207     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  23 in total

1.  The epidemiology of idiopathic dilated cardiomyopathy in a biracial community.

Authors:  S S Coughlin; M Szklo; K Baughman; T A Pearson
Journal:  Am J Epidemiol       Date:  1990-01       Impact factor: 4.897

2.  Factors predicting mortality in idiopathic dilated cardiomyopathy.

Authors:  M Komajda; J P Jais; F Reeves; B Goldfarb; J B Bouhour; Y Juillieres; J Lanfranchi; P Peycelon; P Geslin; D Carrie
Journal:  Eur Heart J       Date:  1990-09       Impact factor: 29.983

3.  Black-white differences in idiopathic dilated cardiomyopathy: the Washington DC dilated Cardiomyopathy Study.

Authors:  S S Coughlin; J R Labenberg; M C Tefft
Journal:  Epidemiology       Date:  1993-03       Impact factor: 4.822

4.  Black-white differences in mortality in idiopathic dilated cardiomyopathy: the Washington, DC, dilated cardiomyopathy study.

Authors:  S S Coughlin; J S Gottdiener; K L Baughman; A Wasserman; E S Marx; M C Tefft; B J Gersh
Journal:  J Natl Med Assoc       Date:  1994-08       Impact factor: 1.798

Review 5.  Idiopathic dilated cardiomyopathy.

Authors:  G W Dec; V Fuster
Journal:  N Engl J Med       Date:  1994-12-08       Impact factor: 91.245

6.  The clinical course of idiopathic dilated cardiomyopathy. A population-based study.

Authors:  D D Sugrue; R J Rodeheffer; M B Codd; D J Ballard; V Fuster; B J Gersh
Journal:  Ann Intern Med       Date:  1992-07-15       Impact factor: 25.391

7.  Diabetes mellitus and risk of idiopathic dilated cardiomyopathy. The Washington, DC Dilated Cardiomyopathy Study.

Authors:  S S Coughlin; D L Pearle; K L Baughman; A Wasserman; M C Tefft
Journal:  Ann Epidemiol       Date:  1994-01       Impact factor: 3.797

8.  Clinical aspects and haemodynamics in the follow-up of dilated cardiomyopathy and myocarditis.

Authors:  F Camerini; R Bussani; D Lenarda; G Lardieri; L Mestroni; D Miani; B Pinamonti; A Salvi; F Silvestri; G Sinagra
Journal:  Eur Heart J       Date:  1991-08       Impact factor: 29.983

9.  The spectrum of left ventricular size in dilated cardiomyopathy: clinical correlates and prognostic implications. SPIC (Italian Multicenter Cardiomyopathy Study) Group.

Authors:  A Gavazzi; R De Maria; G Renosto; A Moro; M Borgia; A Caroli; G Castelli; M Ciaccheri; D Pavan; C De Vita
Journal:  Am Heart J       Date:  1993-02       Impact factor: 4.749

10.  Respiratory illness, beta-agonists, and risk of idiopathic dilated cardiomyopathy. The Washington, DC, Dilated Cardiomyopathy Study.

Authors:  S S Coughlin; C Metayer; E P McCarthy; F J Mather; R E Waldhorn; B J Gersh; S DuPraw; K L Baughman
Journal:  Am J Epidemiol       Date:  1995-08-15       Impact factor: 4.897

View more
  5 in total

1.  Toward Genetics-Driven Early Intervention in Dilated Cardiomyopathy: Design and Implementation of the DCM Precision Medicine Study.

Authors:  Daniel D Kinnamon; Ana Morales; Deborah J Bowen; Wylie Burke; Ray E Hershberger
Journal:  Circ Cardiovasc Genet       Date:  2017-12

2.  Barriers to cardiac transplantation in idiopathic dilated cardiomyopathy: the Washington, DC, Dilated Cardiomyopathy Study.

Authors:  S S Coughlin; S Halabi; C Metayer
Journal:  J Natl Med Assoc       Date:  1998-06       Impact factor: 1.798

3.  Multistep ion channel remodeling and lethal arrhythmia precede heart failure in a mouse model of inherited dilated cardiomyopathy.

Authors:  Takeshi Suzuki; Takao Shioya; Takashi Murayama; Masami Sugihara; Fuminori Odagiri; Yuji Nakazato; Hiroto Nishizawa; Akihito Chugun; Takashi Sakurai; Hiroyuki Daida; Sachio Morimoto; Nagomi Kurebayashi
Journal:  PLoS One       Date:  2012-04-13       Impact factor: 3.240

4.  Regional Variation in the Association of Poverty and Heart Failure Mortality in the 3135 Counties of the United States.

Authors:  Khansa Ahmad; Edward W Chen; Umair Nazir; William Cotts; Ambar Andrade; Amal N Trivedi; Sebhat Erqou; Wen-Chih Wu
Journal:  J Am Heart Assoc       Date:  2019-09-04       Impact factor: 5.501

5.  Omega-3 Fatty acids and vitamin d in cardiology.

Authors:  Norbert Güttler; Kirila Zheleva; Mariana Parahuleva; Ridvan Chasan; Mehmet Bilgin; Christiane Neuhof; Mehmet Burgazli; Bernd Niemann; Ali Erdogan; Andreas Böning
Journal:  Cardiol Res Pract       Date:  2012-12-31       Impact factor: 1.866

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.